Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Granite State Dermatology

Neither a doctor nor a teaching hospital

Research payments

$216,803

185 payments

Through program year 2025, Granite State Dermatology is reported as receiving $216,803 in research payments, across 185 payments.

By program year

4 rows
Year Kind Amount Payments
2025 Research $95,076 2
2024 Research $17,649 80
2023 Research $96,093 94
2022 Research $7,985 9

Breakdown

Who paid Research payments · program years 2022–2025
  1. Eli Lilly and Company $110,639 4 payments
  2. Dermavant Sciences, Inc. $81,311 139 payments
  3. LEO Pharma AS $24,853 42 payments
Studies the money was for Research payments · program years 2022–2025
  1. Observation Priority E Short - Lebrikizumab - Atopic Dermatitis $69,351 1 payment
  2. A Phase 4, open-label study to investigate the efficacy and safety of VTAMA(tapinarof) cream, 1% in the treatment of plaque psoriasis occurring in the head and neck region $68,508 72 payments
  3. A Phase 4, Prospective, Open-Label, Single Arm Study to Assess the Effectiveness of Tirzepatide After Initiation of Ixekizumab in Adult Participants With Moderate-To-Severe Plaque Psoriasis and Obesity Or Overweight in Clinical Practice $25,725 1 payment
  4. Trace Study: Tralokinumab Real World Clinical Use: An Observational Cohort Study of Atopic Dermatitis Patients Prescribed Tralokinumab $24,853 42 payments
  5. Psosa (Psoriasis Special Areas) - A US-Based Single-Arm Prospective Multicenter Observational Study of Nail and Scalp Psoriasis Improvement in Patients Treated With Ixekizumab $13,694 1 payment
  6. A Phase 4, Open-Label Study to Investigate the Efficacy and Safety of Vtama (Tapinarof) Cream, 1% in the Treatment of Plaque Psoriasis Occurring in the Head and Neck Region $12,803 67 payments
  7. Psosa (Psoriasis Special Areas) - A US-Based, Single-Arm, Prospective, Multicenter, Observational Study of Nail and Scalp Psoriasis Improvement in Patients Treated With Ixekizumab $1,869 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record